Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

[
Researchers, in a sense, manipulated each patient’s cancer in an attempt to prevent it from coming back. Read More
https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-1683349419-e1738854797635.jpg?resize=1200,600
https://fortune.com/well/article/personalized-kidney-cancer-vaccine-neovax-dana-farber-clinical-trial/


Lindsey Leake